AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,038,000 | -65.8% | 200,808 | -83.0% | 0.02% | -65.2% |
| Q2 2022 | $8,878,000 | -10.6% | 1,183,676 | +8.5% | 0.07% | +3.0% |
| Q1 2022 | $9,931,000 | +39.4% | 1,091,297 | +7.6% | 0.07% | +39.6% |
| Q4 2021 | $7,122,000 | +3.3% | 1,014,556 | +67.8% | 0.05% | +4.3% |
| Q3 2021 | $6,893,000 | -25.5% | 604,639 | +4.6% | 0.05% | -27.0% |
| Q2 2021 | $9,251,000 | +158.6% | 577,832 | +188.6% | 0.06% | +125.0% |
| Q1 2021 | $3,578,000 | -51.2% | 200,228 | -63.1% | 0.03% | -56.2% |
| Q4 2020 | $7,325,000 | +312.7% | 542,175 | +259.6% | 0.06% | +255.6% |
| Q3 2020 | $1,775,000 | – | 150,790 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |